2013
DOI: 10.1016/j.cytogfr.2013.08.002
|View full text |Cite
|
Sign up to set email alerts
|

ALK1-Smad1/5 signaling pathway in fibrosis development: Friend or foe?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
44
0
3

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 58 publications
(48 citation statements)
references
References 177 publications
1
44
0
3
Order By: Relevance
“…It has been already described that renal levels of phospho-Smad1/5/8 increases after UUO [50]. In the present study, we demonstrate that the levels of Smad1 phosphorylation after UUO are lower in S-ENG + than in WT mice, which suggest a role for the ALK1/Smad1 pathway in the generation of renal fibrosis in the kidney, as previously suggested [56].…”
Section: Accepted Manuscriptsupporting
confidence: 82%
“…It has been already described that renal levels of phospho-Smad1/5/8 increases after UUO [50]. In the present study, we demonstrate that the levels of Smad1 phosphorylation after UUO are lower in S-ENG + than in WT mice, which suggest a role for the ALK1/Smad1 pathway in the generation of renal fibrosis in the kidney, as previously suggested [56].…”
Section: Accepted Manuscriptsupporting
confidence: 82%
“…Consistent with the observed TGFβ levels, we found a significant reduction in cardiac SMAD3 level (p=0.03, Figure 2C) in male IUGR fetuses compared to controls female control and in IUGR were similar. The activin receptor-like kinase-1 (ALK1) is a type I cell-surface receptor for the TGF-β family of proteins and has been shown to play an important role in cardiovascular remodeling [47, 48]. The protein levels of cardiac ALK1 were decreased in male IUGR baboons (p=0.03), while female control and IUGR were similar.…”
Section: Resultsmentioning
confidence: 99%
“…Tumor lesions from patients treated with cediranib displayed a selective down-regulation of angiopoietin 2 (ANGPT2) and the up-regulation of its receptor TIE2. This opposite gene modulation may favor the angiopoietin 1 (ANGPT1)-TIE2 interaction and, together with the down-modulation of VEGFR1 (FLT1) and VEGFR2 (KDR), drive a physiological normalization of the vasculature at tumor site [2]. This hypothesis is also supported by the findings that genes encoding for proteins expressed by endothelial precursor cells or by the tumor-associated neo-vasculature such as Folate receptor 1 (FOLH1, known also as PMSA), CXCR7 and ESM1, [3-6] were also down-modulated.…”
Section: Commentarymentioning
confidence: 99%